Literature DB >> 27773421

Dominant Transmission Observed in Adolescents and Families With Orthostatic Intolerance.

Jennifer E Posey1, Rebecca Martinez2, Jeremy E Lankford3, James R Lupski4, Mohammed T Numan5, Ian J Butler3.   

Abstract

BACKGROUND: Orthostatic intolerance is typically thought to be sporadic and attributed to cerebral autonomic dysfunction. We sought to identify families with inherited autonomic dysfunction manifest as symptomatic orthostatic intolerance to characterize mode of inheritance and clinical features.
METHODS: Sixteen families with two or more first- or second-degree relatives with autonomic dysfunction and orthostatic intolerance were enrolled. A clinical diagnosis of autonomic dysfunction defined by symptomatic orthostatic intolerance diagnosed by head-up tilt table testing was confirmed for each proband. Clinical features and evaluation were obtained from each proband using a standardized intake questionnaire, and family history information was obtained from probands and available relatives.
RESULTS: Comprehensive pedigree analysis of 16 families (39 individuals with orthostatic intolerance and 40 individuals suspected of having orthostatic intolerance) demonstrated dominant transmission of autonomic dysfunction with incomplete penetrance. Affected individuals were predominantly female (71.8%, 28/39; F:M, 2.5:1). Male-to-male transmission, although less common, was observed and demonstrated to transmit through unaffected males with an affected parent. Similar to sporadic orthostatic intolerance, probands report a range of symptoms across multiple organ systems, with headaches and neuromuscular features being most common.
CONCLUSIONS: Familial occurrence and vertical transmission of autonomic dysfunction in 16 families suggest a novel genetic syndrome with dominant transmission, incomplete penetrance, and skewing of the sex ratio. Elucidation of potential genetic contributions to orthostatic intolerance may inform therapeutic management and identification of individuals at risk. Adolescent evaluation should include identification and treatment of potential at-risk relatives.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  autonomic nervous system disease; familial autonomic dysfunction; genetic; heredity; orthostatic intolerance; postural orthostatic tachycardia syndrome; primary dysautonomia

Mesh:

Year:  2016        PMID: 27773421      PMCID: PMC5209259          DOI: 10.1016/j.pediatrneurol.2016.09.013

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  31 in total

Review 1.  Malignant vasovagal syncope: prolonged asystole provoked by head-up tilt. Case report and review of diagnosis, pathophysiology, and therapy.

Authors:  J D Maloney; F J Jaeger; F M Fouad-Tarazi; H H Morris
Journal:  Cleve Clin J Med       Date:  1988 Nov-Dec       Impact factor: 2.321

2.  The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing.

Authors:  B P Grubb; D J Kosinski; K Boehm; K Kip
Journal:  Pacing Clin Electrophysiol       Date:  1997-09       Impact factor: 1.976

3.  Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency.

Authors:  J R Shannon; N L Flattem; J Jordan; G Jacob; B K Black; I Biaggioni; R D Blakely; D Robertson
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

4.  Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics.

Authors:  Helle K Iversen; Jes Olesen; Peer Tfelt-Hansen
Journal:  Pain       Date:  1989-07       Impact factor: 6.961

5.  Prevalence of family history in vasovagal syncope and haemodynamic response to head up tilt in first degree relatives: preliminary data for the Newcastle cohort.

Authors:  Julia L Newton; Roseanne Kenny; Joanna Lawson; Richard Frearson; Peter Donaldson
Journal:  Clin Auton Res       Date:  2003-02       Impact factor: 4.435

6.  Comorbid Conditions Do Not Differ in Children and Young Adults with Functional Disorders with or without Postural Tachycardia Syndrome.

Authors:  Gisela Chelimsky; Katja Kovacic; Melodee Nugent; Adriane Mueller; Pippa Simpson; Thomas C Chelimsky
Journal:  J Pediatr       Date:  2015-04-25       Impact factor: 4.406

7.  Autosomal dominant vasovagal syncope: clinical features and linkage to chromosome 15q26.

Authors:  Karl Martin Klein; Catherine J Bromhead; Katherine R Smith; Christopher J O'Callaghan; Susan J Corcoran; Sarah E Heron; Xenia Iona; Bree L Hodgson; Jacinta M McMahon; Kate M Lawrence; Ingrid E Scheffer; Leanne M Dibbens; Melanie Bahlo; Samuel F Berkovic
Journal:  Neurology       Date:  2013-04-16       Impact factor: 9.910

8.  Cardiac asystole during head up tilt (HUTT) in children and adolescents: is this benign physiology?

Authors:  Mohammed Numan; Rawan Alnajjar; Jeremy Lankford; Anand Gourishankar; Ian Butler
Journal:  Pediatr Cardiol       Date:  2014-08-03       Impact factor: 1.655

Review 9.  Vasovagal syncope: state or trait?

Authors:  Anna Serletis Bizios; Robert S Sheldon
Journal:  Curr Opin Cardiol       Date:  2009-01       Impact factor: 2.161

10.  Familial vasovagal syncope associated with migraine.

Authors:  Ahmad Daas; Aviva Mimouni-Bloch; Shlomit Rosenthal; Avinoam Shuper
Journal:  Pediatr Neurol       Date:  2009-01       Impact factor: 3.372

View more
  1 in total

1.  Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting - Part 2.

Authors:  Satish R Raj; Kate M Bourne; Lauren E Stiles; Mitchell G Miglis; Melissa M Cortez; Amanda J Miller; Roy Freeman; Italo Biaggioni; Peter C Rowe; Robert S Sheldon; Cyndya A Shibao; Andre Diedrich; David M Systrom; Glen A Cook; Taylor A Doherty; Hasan I Abdallah; Blair P Grubb; Artur Fedorowski; Julian M Stewart; Amy C Arnold; Laura A Pace; Jonas Axelsson; Jeffrey R Boris; Jeffrey P Moak; Brent P Goodman; Kamal R Chémali; Tae H Chung; David S Goldstein; Anil Darbari; Steven Vernino
Journal:  Auton Neurosci       Date:  2021-06-30       Impact factor: 2.355

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.